Publications by authors named "Steven Andresen"

Claim this Profile
I
Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.
Moaath Mustafa Ali, Donna M Corrigan, Lisa A Rybicki, Melissa A Yurch, Kelly Cherni, Steven Andresen

Hematol Oncol Stem Cell Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
Jack Khouri, Lisa Rybicki, Navneet Majhail, Matt Kalaycio, Edward Copelan, Steven Andresen

J Clin Apher· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.
Yazeed Sawalha, Brian T Hill, Lisa A Rybicki, Danyu Sun, Robert M Dean, Steven Andresen

Clin Lymphoma Myeloma Leuk· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Moaath Mustafa Ali, Donna M Abounader, Lisa A Rybicki, Melissa A Yurch, Jamie Starn, Steven Andresen

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Brian T Hill, Lisa Rybicki, Kelley D Carlstrom, Deepa Jagadeesh, Aaron Gerds, Steven Andresen

Biol Blood Marrow Transplant· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, Steven Andresen, Matt Kalaycio

Hematol Oncol Stem Cell Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.
Aleksandr Lazaryan, Mohamad A Hussein, Frederic J Reu, Beth Faiman, Becky Habecker, Steven Andresen

Am J Hematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Nelli Bejanyan, Brian J Bolwell, Aleksandr Lazaryan, Lisa Rybicki, Shawnda Tench, Steven Andresen

Biol Blood Marrow Transplant· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
Hien K Duong, Brian J Bolwell, Lisa Rybicki, Anna Koo, Eric D Hsi, Steven Andresen

J Clin Apher· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D level after allogeneic hematopoietic stem cell transplant.
Lisa Sproat, Brian Bolwell, Lisa Rybicki, Robert Dean, Ronald Sobecks, Steven Andresen

Biol Blood Marrow Transplant· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Brian T Hill, Lisa Rybicki, Stephen Smith, Robert Dean, Matt Kalaycio, Steven Andresen

Leuk Lymphoma· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.
Stephen D Smith, Craig H Moskowitz, Robert Dean, Brad Pohlman, Ronald Sobecks, Steven Andresen

Br J Haematol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
Brian T Hill, Lisa Rybicki, Brian J Bolwell, Stephen Smith, Robert Dean, Steven Andresen

Br J Haematol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients.
Ronald M Sobecks, Edward Copelan, Matt Kalaycio, Medhat Askar, Lisa Rybicki, Steven Andresen

Br J Haematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
Brian T Hill, Brian J Bolwell, Lisa Rybicki, Robert Dean, Matt Kalaycio, Steven Andresen

Biol Blood Marrow Transplant· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission.
Lisa Sproat, Brian Bolwell, Lisa Rybicki, Shawnda Tench, Josephine Chan, Steven Andresen

Leuk Lymphoma· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.
Robert M Dean, Brad Pohlman, John W Sweetenham, Ronald M Sobecks, Matt E Kalaycio, Steven Andresen

Br J Haematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma.
Stephen D Smith, Brian J Bolwell, Anjali S Advani, Steven W Andresen, Josephine L Chan

Leuk Lymphoma· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Navin Wadehra, Sherif Farag, Brian Bolwell, Patrick Elder, Sam Penza

Biol Blood Marrow Transplant· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trial.
Rony M Abou-Jawde, Janice Reed, Megan Kelly, Esteban Walker, Steven Andresen

Med Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Revathi Suppiah, Philip E Shaheen, Paul Elson, Seema A Misbah, Laura Wood, Steven W Andresen

Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Matt Kalaycio, Lisa Rybicki, Brad Pohlman, Ronald Sobecks, Steven Andresen

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.
Mohamad A Hussein, Rachid Baz, Gordan Srkalovic, Neeraj Agrawal, Revathi Suppiah, Steven Andresen

Mayo Clin Proc· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Rachid Baz, Liang Li, Kandice Kottke-Marchant, Gordan Srkalovic, Bridget McGowan, Steven Andresen

Mayo Clin Proc· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirtazapine for pruritus.
Mellar P Davis, Jan L Frandsen, Declan Walsh, Steven Andresen, Sandy Taylor

J Pain Symptom Manage· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis